SHC EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
SHC's ev/ebitda is lower than 65% of the last 10 years.
EV/EBITDA History
SHC EV/EBITDA by year
Yearly range of SHC’s ev/ebitda from 2020 to 2026. Over the full period it ranged from 8.2 to 32.3, averaging 17.3.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 12.4 | 13.9 | 16.7 | 13.6 |
| 2025 | 11.6 | 14.1 | 16.6 | 15.6 |
| 2024 | 12.0 | 14.0 | 17.1 | 13.5 |
| 2022 | 8.2 | 15.6 | 20.5 | 9.9 |
| 2021 | 20.7 | 26.2 | 29.1 | 20.7 |
| 2020 | 27.4 | 31.2 | 32.3 | 27.4 |
Get notified when SHC EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is SHC EV/EBITDA High or Low Right Now?
Sotera Health Company's EV/EBITDA is currently 13.6, which is below average relative to its 10-year historical range. The 10-year median EV/EBITDA for SHC is approximately 15.5. See all SHC valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.